Fleury S.A. (FLRY3.SA)
São Paulo · BRL · Healthcare · Diagnostics & Research
R$22.10 (-20.70%) as of
Key statistics
- Market cap
- 12.01B
- P/E (TTM)
- 19.05
- Forward P/E
- 13.14
- EPS (TTM)
- 1.16
- Dividend yield
- 5.88%
- 52-week range
- 0.00 – 28.65
- Revenue (TTM)
- 8.79B
- Profit margin
- 8.01%
- Analyst target
- R$22.17
About Fleury S.A.
Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medicine, orthopedics, ophthalmology, toxicological tests, fertility, infusions, and others. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- São Paulo, SP, Brazil
- Employees
- 28,000
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.